Winton Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,384
| Closed | -$229K | – | 1015 |
|
|
2025
Q1 | $229K | Sell |
35,384
-56,851
| -62% | -$368K | 0.01% | 608 |
|
|
2024
Q4 | $677K | Sell |
92,235
-38,730
| -30% | -$284K | 0.05% | 420 |
|
|
2024
Q3 | $981K | Buy |
130,965
+31,254
| +31% | +$234K | 0.07% | 330 |
|
|
2024
Q2 | $887K | Buy |
99,711
+18,668
| +23% | +$166K | 0.06% | 341 |
|
|
2024
Q1 | $821K | Buy |
+81,043
| New | +$821K | 0.06% | 371 |
|
|
2023
Q4 | – | Sell |
-14,943
| Closed | -$140K | – | 862 |
|
|
2023
Q3 | $140K | Sell |
14,943
-5,028
| -25% | -$47.1K | 0.01% | 699 |
|
|
2023
Q2 | $490K | Sell |
19,971
-50,017
| -71% | -$1.23M | 0.04% | 329 |
|
|
2023
Q1 | $1.63M | Buy |
69,988
+17,249
| +33% | +$401K | 0.1% | 272 |
|
|
2022
Q4 | $1.33M | Sell |
52,739
-4,903
| -9% | -$124K | 0.09% | 326 |
|
|
2022
Q3 | $1.11M | Buy |
57,642
+9,871
| +21% | +$190K | 0.07% | 376 |
|
|
2022
Q2 | $1.22M | Buy |
47,771
+32,432
| +211% | +$826K | 0.06% | 422 |
|
|
2022
Q1 | $395K | Buy |
15,339
+2,325
| +18% | +$59.9K | 0.02% | 745 |
|
|
2021
Q4 | $545K | Sell |
13,014
-720
| -5% | -$30.2K | 0.03% | 652 |
|
|
2021
Q3 | $598K | Buy |
13,734
+609
| +5% | +$26.5K | 0.03% | 768 |
|
|
2021
Q2 | $621K | Buy |
13,125
+1,875
| +17% | +$88.7K | 0.03% | 798 |
|
|
2021
Q1 | $577K | Sell |
11,250
-3,844
| -25% | -$197K | 0.03% | 797 |
|
|
2020
Q4 | $404K | Sell |
15,094
-37,077
| -71% | -$992K | 0.03% | 897 |
|
|
2020
Q3 | $1.79M | Buy |
+52,171
| New | +$1.79M | 0.06% | 581 |
|